Research Comment

| RESEARCH

Coffee Stain (COFFEEB)

Research Comment

Coffee Stain (COFFEEB): The Market Bought the Review Bomb. Unwarranted.

Kristoffer Lindström

May 21, 2026

Smart Eye (SEYE)

Research Comment

Smart Eye (SEYE): Seeing Machines Q3 Confirms the EU Pre-Build. Smart Eye Consensus Looks Wrong.

Kristoffer Lindström

May 7, 2026

Carasent (CARA)

Smart Eye (SEYE)

cBrain (CBRAIN)

Klarna (KLAR)

Flat Capital (FLATB)

Research Comment

The EU AI Act Gets a 16-Month Extension; Some Nordic Names Benefit More Than Others.

Kristoffer Lindström

Mar 30, 2026

Sleep Cycle (SLEEP)

Research Comment

Sleep Cycle (SLEEP): Major SDK Licensing Deal Announced

Kristoffer Lindström

Dec 18, 2025

Embracer Group (EMBRACB)

Research Comment

Embracer (EMBRACB): Soft Quarter Ahead of CSG Spin-Off

Kristoffer Lindström

Nov 14, 2025

Physitrack (PTRK)

Research Comment

Physitrack (PTRK): Market Misses the Cash-Flow and SaaS Quality Shift - Earnings comment

Kristoffer Lindström

Oct 24, 2025

Sleep Cycle (SLEEP)

Research Comment

Sleep Cycle (SLEEP): Diversification Gaining Momentum, but Capital Allocation Now Critical - Earnings comment

Kristoffer Lindström

Oct 24, 2025

Carasent (CARA)

Research Comment

Why Carasent (CARA) Stock Is Up Today

Kristoffer Lindström

Oct 16, 2025

Cheffelo (CHEF)

Research Comment

Why Cheffelo (CHEF) Stock Is Soaring Today - Price Alert

Kristoffer Lindström

Oct 10, 2025

Date

Report

→

5/21/2026

Coffee Stain (COFFEEB): The Market Bought the Review Bomb. Unwarranted.

Coffee Stain (COFFEEB)

Research Comment

→

5/7/2026

Smart Eye (SEYE): Seeing Machines Q3 Confirms the EU Pre-Build. Smart Eye Consensus Looks Wrong.

Smart Eye (SEYE)

Research Comment

→

3/30/2026

The EU AI Act Gets a 16-Month Extension; Some Nordic Names Benefit More Than Others.

Carasent (CARA)

Smart Eye (SEYE)

cBrain (CBRAIN)

Klarna (KLAR)

Flat Capital (FLATB)

Research Comment

→

12/18/2025

Sleep Cycle (SLEEP): Major SDK Licensing Deal Announced

Sleep Cycle (SLEEP)

Research Comment

→

11/14/2025

Embracer (EMBRACB): Soft Quarter Ahead of CSG Spin-Off

Embracer Group (EMBRACB)

Research Comment

→

10/24/2025

Physitrack (PTRK): Market Misses the Cash-Flow and SaaS Quality Shift - Earnings comment

Physitrack (PTRK)

Research Comment

→

10/24/2025

Sleep Cycle (SLEEP): Diversification Gaining Momentum, but Capital Allocation Now Critical - Earnings comment

Sleep Cycle (SLEEP)

Research Comment

→

10/16/2025

Why Carasent (CARA) Stock Is Up Today

Carasent (CARA)

Research Comment

→

10/10/2025

Why Cheffelo (CHEF) Stock Is Soaring Today - Price Alert

Cheffelo (CHEF)

Research Comment

→

Independent | Professional | Unbiased

Research Comment

| RESEARCH

Coffee Stain (COFFEEB): The Market Bought the Review Bomb. Unwarranted.

Smart Eye (SEYE): Seeing Machines Q3 Confirms the EU Pre-Build. Smart Eye Consensus Looks Wrong.

The EU AI Act Gets a 16-Month Extension; Some Nordic Names Benefit More Than Others.

Sleep Cycle (SLEEP): Major SDK Licensing Deal Announced

Embracer (EMBRACB): Soft Quarter Ahead of CSG Spin-Off

Physitrack (PTRK): Market Misses the Cash-Flow and SaaS Quality Shift - Earnings comment

Sleep Cycle (SLEEP): Diversification Gaining Momentum, but Capital Allocation Now Critical - Earnings comment

Why Carasent (CARA) Stock Is Up Today

Why Cheffelo (CHEF) Stock Is Soaring Today - Price Alert

Coffee Stain (COFFEEB): The Market Bought the Review Bomb. Unwarranted.

Smart Eye (SEYE): Seeing Machines Q3 Confirms the EU Pre-Build. Smart Eye Consensus Looks Wrong.

The EU AI Act Gets a 16-Month Extension; Some Nordic Names Benefit More Than Others.

Sleep Cycle (SLEEP): Major SDK Licensing Deal Announced

Embracer (EMBRACB): Soft Quarter Ahead of CSG Spin-Off

Physitrack (PTRK): Market Misses the Cash-Flow and SaaS Quality Shift - Earnings comment

Sleep Cycle (SLEEP): Diversification Gaining Momentum, but Capital Allocation Now Critical - Earnings comment

Why Carasent (CARA) Stock Is Up Today

Why Cheffelo (CHEF) Stock Is Soaring Today - Price Alert

SUBSCRIBE TO LIND RESEARCH

Lind Research